Max Robotics — Global Service Robot Directory + US Certification

About

Russell B. McBride is a clinical researcher whose work focuses on improving outcomes in prostate cancer, particularly through the lens of health disparities and the influence of common medications on disease presentation and treatment. His most cited study, "Decisional regret after robotic-assisted laparoscopic prostatectomy is higher in African American men" (2014, 36 citations), is a landmark contribution to the field of surgical equity, directly addressing how race and shared decision-making affect long-term patient satisfaction. This work highlights a critical gap in urologic oncology, showing that African American men experience significantly higher regret after robotic prostatectomy, a finding that has spurred conversations around culturally competent counseling. McBride has also explored the intersection of metabolic syndrome and surgical outcomes, and his research on preoperative statin use (2017) investigates whether these drugs lower PSA levels without affecting prostate size, potentially misleading active surveillance eligibility. With additional work on how benign prostate enlargement medications modulate Gleason score upgrading, McBride’s portfolio demonstrates a consistent focus on refining risk stratification and personalizing care. His contributions, though modest in citation volume, are highly targeted and clinically actionable, making him a valuable voice in the push for more equitable and nuanced prostate cancer management.